Todas as matérias desta categoria, das mais recentes às mais antigas.
Chemomab Therapeutics (NASDAQ:CMMB) reported second-quarter 2026 results and progress on its proposed all-stock merger with Scipher Medicine, with Chemomab shareholders expected to own about 32% of a combined company valued at $150 million.
Galmed Pharmaceuticals (NASDAQ:GLMD) announced that its wholly owned subsidiary Colospan completed a first-in-human feasibility study of a colon tissue quality assessment platform in 32 colorectal cancer patients undergoing elective surgery.
Lindsay Rosner, head of multi-sector fixed income investing at Goldman Sachs Asset Management, examines the impact of AI debt on the demand for long-end US Treasuries. Rosner also says she doesn't expect much clarity in the FOMC meeting minutes on the central bank's reaction function.
Veralto (NYSE:VLTO) signed a definitive agreement to acquire Cleanwater1 for $465 million, with an estimated net purchase price of $452 million after tax benefits.
Datavault AI (NASDAQ:DVLT) reported second-quarter 2026 revenue of $6.7 million, up $5 million or 287% year over year, as the company expanded its data monetization and tokenization platforms.
Antalpha (NASDAQ:ANTA) reported unaudited second-quarter 2026 revenue of $12.2 million, down 28% year over year, mainly due to lower technology financing fees following the wind-down of the Cango facility.
Viking Holdings (NYSE:VIK) reported second-quarter 2026 revenue of $2.19 billion, up 16.5% year over year, with adjusted EBITDA increasing 18.2% to $748.4 million.
Edward Yardeni, president at Yardeni Research, explains why interest rates at 4% - 5% are "a healthy sign of a healthy economy."
TJX Companies (NYSE:TJX) reported second-quarter fiscal 2027 net sales of $15.2 billion, up 5% year over year, with consolidated comparable sales increasing 4%.
ZIM Integrated Shipping Services (NYSE:ZIM) reported second-quarter 2026 revenue of $1.78 billion, up 9% year over year, with net income increasing to $64 million from $24 million.
Aurora Cannabis (NASDAQ:ACB) confirmed that Curaleaf Holdings has commenced an unsolicited takeover bid for all Aurora common shares, offering implied consideration of US$4 per share.
Analog Devices (NASDAQ:ADI) reported record fiscal third-quarter 2026 revenue of $4.02 billion, up 40% year over year, with growth led by Data Center and Industrial markets.
